Valedo and minority shareholders have entered into an agreement to divest Solhagagruppen AB, Sweden’s leading full responsibility LSS1 provider, to Bridgepoint Development Capital.
Valedo acquired a majority stakehold in Solhagagruppen in 2007 alongside the founding family and since first entering Solhagagruppen, Valedo initiated an accelerated development and growth phase and over the past three years, the company has evolved from a local provider of LSS-services to adults into the Sweden’s leading LSSprovider offering a complete range of LSS and associated services throughout Sweden that spans over a user’s entire lifetime. Under Valedo’s ownership, sales have tripled increasing from SEK ~100 m to SEK ~300 m annually and Solhagagruppen has completed five acquisitions to strengthen and complement is offering.
“Over the last three years Solhagagruppen has been working in close collaboration with Valedo during which time we have more than tripled in size, broadened our service and care offering, and established ourselves as the leading focused LSS-provider in Sweden with a clear focus on quality of care. We are very enthusiastic about the future and we are confident of successfully continuing our growth path and strategic development with the support of Bridgepoint.” says Saila Ström, CEO of Solhagagruppen.
Terms of the agreed transaction, which are subject to regulatory approvals, are not disclosed.
Media Contacts for Valedo:
Media Contacts for Solhagagruppen:
Valedo is an independent Swedish private equity fund managing SEK 1 billion for investments in high-quality small/mid cap companies in the Nordic region. Valedo is focusing on companies with clear growth and development potential where Valedo can actively contribute to and accelerate the companies’ development. Being an active owner and contributing both capital and industrial experience, Valedo ensures that a company can achieve its full potential. For more information, please visit www.valedopartners.com.
About Solhagagruppen: Solhagagruppen is Sweden’s leading focused provider of full responsibility LSS1 and associated services to children, youth and adults with functional impairments, with a clear focus on users with autism spectrum disorders and related diagnoses. The Company offers a unique range of services, which spans a whole life time for the users and includes group- and assisted living, daily activities, diagnosis and care, pre-school, boarding school and summer camp. Quality of care is a key success factor behind Solhagagruppen’s market position and growth, and the Company is continuously developing its operations to offer a “best in class” care. Solhagagruppen is offering its services in the Greater Stockholm Area, Västra Götaland, Skåne, and in Norrland. Headquartered in Stockholm, the Company employs over 450 full-time employees catering to more than 300 individual contracts. For more information, please visit www.solhagagruppen.se.
Bridgepoint Development Capital provides funding to businesses headquartered in France, the Nordic region and the UK, typically buyouts valued up to €200 million. It is part of Bridgepoint, the international private equity group, which invests in businesses valued between €200 million and €1 billion across Europe, from a network of eight offices in Frankfurt, Istanbul, London, Madrid, Milan, Paris, Stockholm and Warsaw. Bridgepoint has a long record of investing in health care companies, and has in the Nordic region invested in companies such as Terveystalo (Finland) and Diaverum (Sweden). Since 1986, Bridgepoint has made over 45 investments in the health care sector. For more information, please visit www.bridgepoint.eu.